Compounds > isopentenyladenosine
Page last updated: 2024-08-22

isopentenyladenosine and Bladder Cancer

isopentenyladenosine has been researched along with Bladder Cancer in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baldoli, E; Casati, S; Ciuffreda, P; Maier, JA; Manzocchi, A; Mariotti, M; Ottria, R1
Casati, S; Ciuffreda, P; Maier, JA; Mariotti, M; Ottria, R1
Casati, S; Castiglioni, S; Ciuffreda, P; Maier, JA; Ottria, R1

Other Studies

3 other study(ies) available for isopentenyladenosine and Bladder Cancer

ArticleYear
Synthesis and evaluation of in vitro anticancer activity of some novel isopentenyladenosine derivatives.
    Bioorganic & medicinal chemistry, 2010, Jun-15, Volume: 18, Issue:12

    Topics: Antineoplastic Agents; Cell Line, Tumor; Humans; Isopentenyladenosine; Urinary Bladder Neoplasms

2010
Novel isopentenyladenosine analogues: synthesis, characterization, and evaluation of antiproliferative activity on bladder carcinoma cells.
    Nucleosides, nucleotides & nucleic acids, 2009, Volume: 28, Issue:8

    Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Drug Design; Humans; Isopentenyladenosine; Molecular Structure; Urinary Bladder Neoplasms

2009
N6-isopentenyladenosine and its analogue N6-benzyladenosine induce cell cycle arrest and apoptosis in bladder carcinoma T24 cells.
    Anti-cancer agents in medicinal chemistry, 2013, Volume: 13, Issue:4

    Topics: Adenosine; Antineoplastic Agents; Apoptosis; Cell Cycle; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Isopentenyladenosine; Molecular Structure; Structure-Activity Relationship; Tumor Cells, Cultured; Urinary Bladder Neoplasms

2013